Learn about Allantoin, a dermatological agent for wound healing and skin repair. Dosage, uses, and safety information.
Browse our catalog for available pharmaceutical products and competitive pricing.
Allantoin is a pharmaceutical compound classified under ATC code D03, designated for dermatological and wound care applications. This naturally occurring chemical compound has been utilized in pharmaceutical formulations for over a century due to its remarkable therapeutic properties in promoting tissue repair and skin regeneration.
Allantoin is an organic compound derived from uric acid metabolism or synthesized chemically. It appears as a white to off-white crystalline powder and is highly soluble in hot water. The compound is widely recognized in pharmaceutical and cosmetic industries as an active ingredient in topical formulations designed to enhance skin health and accelerate healing processes.
The therapeutic efficacy of Allantoin operates through several biological mechanisms:
Allantoin is primarily indicated for dermatological conditions requiring accelerated healing. Clinical applications include:
Allantoin is administered exclusively via topical application. Typical pharmaceutical formulations contain concentrations ranging from 0.5% to 2%. The compound is available in creams, ointments, gels, and solution preparations. Application should be performed 1-3 times daily directly to affected areas following gentle cleansing of the skin. Healthcare providers should determine specific dosing protocols based on the severity and nature of the condition being treated.
Allantoin demonstrates an excellent safety profile with minimal adverse effects reported. Potential side effects are rare but may include:
The compound is generally well-tolerated across all age groups and can be safely used during pregnancy and lactation.
While Allantoin is considered safe, certain precautions should be observed. Avoid application to open wounds with signs of severe infection without medical supervision. Discontinue use if allergic reactions or severe irritation develop. Allantoin formulations should not be applied to eyes or mucous membranes. Patients with known hypersensitivity to the compound should avoid use. For extensive wounds or severe skin conditions, professional medical evaluation is recommended prior to treatment initiation.
In conclusion, Allantoin represents a valuable therapeutic option in dermatological care, offering efficacy in wound management with minimal adverse effects.